Custom Search Insider Trading Activity Insider Trading Activity
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
Custom Search Insider Trading Activity
Updated Apr 2, 2024
Ticker
|
Company Name
|
Qty.
|
Price
|
Size ($)
|
Filing Date
|
Type
|
Δ Own
|
Own
|
Insider Names
|
Title
|
Trade Dates
|
Is Scheduled
| |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Intra-Cellular Therapies, Inc.
| 79 |
$69.20 | $5,466.80 | +0.82% | 9.69K |
Mar 31
| |||||||
Yield10 Bioscience, Inc.
| 11.92K |
—
|
—
| +32.48% | 48.63K |
Mar 28
| |||||||
Intra-Cellular Therapies, Inc.
|
0
|
$45.75 | -$1,087,450.07 |
—
| 9.61K |
Feb 27
| |||||||
Sellas Life Sciences Group, Inc.
| 6K |
—
|
—
| +136.36% | 10.4K |
Jan 22
| |||||||
Intra-Cellular Therapies, Inc.
| 76 |
$71.62 | $5,443.12 | +0.80% | 9.61K |
Dec 31
| |||||||
Yield10 Bioscience, Inc.
| 18.88K |
—
|
—
| +105.87% | 36.71K |
Dec 29
| |||||||
Intra-Cellular Therapies, Inc.
| 105 |
$52.09 | $5,469.45 | +1.11% | 9.54K |
Sep 30
| |||||||
Yield10 Bioscience, Inc.
| 13.87K |
—
|
—
| +349.85% | 17.83K |
Sep 29
| |||||||
Intra-Cellular Therapies, Inc.
| 85 |
$63.32 | $5,382.20 | +0.91% | 9.43K |
Jun 30
| |||||||
Yield10 Bioscience, Inc.
| 2.04K |
—
|
—
| +106.03% | 3.96K |
Jun 30
| |||||||
Intra-Cellular Therapies, Inc.
|
0
|
—
|
—
|
—
|
0
|
Jun 23
| |||||||
Yield10 Bioscience, Inc.
|
0
|
—
|
—
|
—
|
0
|
May 25
| |||||||
Intra-Cellular Therapies, Inc.
|
0
|
$38.03 | -$499,500.00 |
—
| 9.35K |
Apr 17
| |||||||
Yield10 Bioscience, Inc.
| 1.64K |
—
|
—
| +582.27% | 1.92K |
Mar 31
| |||||||
Intra-Cellular Therapies, Inc.
| 95 |
$54.15 | $5,144.25 | +1.03% | 9.35K |
Mar 31
| |||||||
Sellas Life Sciences Group, Inc.
| 2.5K |
—
|
—
| +131.58% | 4.4K |
Feb 2
| |||||||
Yield10 Bioscience, Inc.
|
0
|
—
|
—
|
—
|
0
|
Dec 31
| |||||||
Intra-Cellular Therapies, Inc.
| 97 |
$52.92 | $5,133.24 | +1.06% | 9.25K |
Dec 30
| |||||||
Intra-Cellular Therapies, Inc.
| 110 |
$46.53 | $5,118.30 | +1.22% | 9.15K |
Sep 30
| |||||||
Yield10 Bioscience, Inc.
|
0
|
—
|
—
|
—
|
0
|
Sep 30
| |||||||
Intra-Cellular Therapies, Inc.
|
0
|
$34.89 | -$1,334,475.00 |
—
| 9.04K |
Aug 11
| |||||||
Intra-Cellular Therapies, Inc.
| 108 |
$57.08 | $6,164.64 | +1.21% | 9.04K |
Jun 30
| |||||||
Yield10 Bioscience, Inc.
|
0
|
—
|
—
|
—
|
0
|
Jun 30
| |||||||
Intra-Cellular Therapies, Inc.
|
0
|
—
|
—
|
—
|
0
|
Jun 9
| |||||||
Yield10 Bioscience, Inc.
|
0
|
—
|
—
|
—
|
0
|
May 25
| |||||||
Yield10 Bioscience, Inc.
|
0
|
—
|
—
|
—
|
0
|
Mar 31
| |||||||
Intra-Cellular Therapies, Inc.
| 126 |
$61.19 | $7,709.94 | +1.43% | 8.94K |
Mar 31
| |||||||
Sellas Life Sciences Group, Inc.
| 1.9K |
—
|
—
|
∞
| 1.9K |
Jan 31
| |||||||
Intra-Cellular Therapies, Inc.
| 148 |
$52.34 | $7,746.32 | +1.71% | 8.81K |
Dec 31
| |||||||
Yield10 Bioscience, Inc.
|
0
|
—
|
—
|
—
|
0
|
Dec 31
| |||||||
Intra-Cellular Therapies, Inc.
| 215 |
$37.28 | $8,015.20 | +2.55% | 8.66K |
Sep 30
| |||||||
Yield10 Bioscience, Inc.
|
0
|
—
|
—
|
—
|
0
|
Sep 30
| |||||||
Intra-Cellular Therapies, Inc.
| 173 |
$40.82 | $7,061.86 | +2.09% | 8.45K |
Jun 30
| |||||||
Yield10 Bioscience, Inc.
|
0
|
—
|
—
|
—
|
0
|
Jun 30
| |||||||
Intra-Cellular Therapies, Inc.
|
0
|
—
|
—
|
—
|
0
|
Jun 21
| |||||||
Yield10 Bioscience, Inc.
|
0
|
—
|
—
|
—
|
0
|
May 24
| |||||||
Intra-Cellular Therapies, Inc.
| 208 |
$33.93 | $7,057.44 | +2.58% | 8.27K |
Mar 31
| |||||||
Yield10 Bioscience, Inc.
|
0
|
—
|
—
|
—
|
0
|
Mar 31
| |||||||
Sellas Life Sciences Group, Inc.
|
0
|
—
|
—
|
—
|
0
|
Mar 4
| |||||||
Intra-Cellular Therapies, Inc.
| 222 |
$31.80 | $7,059.60 | +2.83% | 8.06K |
Dec 31
| |||||||
It looks like there's no data for these filter options. Maybe you'll be interested in these options instead. | |||||||||||||
Want to view more results?
Unlock the hidden results with your Benzinga Account now. No purchase required.